{"id":105612,"date":"2024-03-25T23:11:00","date_gmt":"2024-03-25T23:11:00","guid":{"rendered":"https:\/\/quixnet.net\/fda-approves-new-drug-that-may-help-stop-and-even-reverse-a-rare-fatal-condition-that-doctors-call-a-ticking-time-bomb-cnn\/"},"modified":"2024-03-25T23:11:00","modified_gmt":"2024-03-25T23:11:00","slug":"fda-approves-new-drug-that-may-help-stop-and-even-reverse-a-rare-fatal-condition-that-doctors-call-a-ticking-time-bomb-cnn","status":"publish","type":"post","link":"https:\/\/quixnet.net\/wpinstance\/fda-approves-new-drug-that-may-help-stop-and-even-reverse-a-rare-fatal-condition-that-doctors-call-a-ticking-time-bomb-cnn\/","title":{"rendered":"FDA approves new drug that may help stop and even reverse a rare, fatal condition that doctors call a \u2018ticking time bomb\u2019 – CNN"},"content":{"rendered":"
\n
    \n
  1. FDA approves new drug that may help stop and even reverse a rare, fatal condition that doctors call a ‘ticking time bomb’<\/a>CNN<\/font><\/li>\n
  2. FDA approves Merck’s drug for rare, deadly lung condition<\/a>CNBC<\/font><\/li>\n
  3. FDA Approves Potential ‘Game Changer’ for Pulmonary Arterial Hypertension<\/a>BioSpace<\/font><\/li>\n
  4. Merck’s (MRK) Winrevair for Rare High Blood Pressure Disorder Approved by FDA<\/a>Bloomberg<\/font><\/li>\n
  5. Merck’s $11.5 Billion Bet on Its Next Big Drug Finally Arrives<\/a>The Wall Street Journal<\/font><\/li>\n<\/ol>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

    FDA approves new drug that may help stop and even reverse a rare, fatal condition that doctors call a ‘ticking time bomb’CNN FDA approves Merck’s drug for rare, deadly lung conditionCNBC FDA Approves Potential ‘Game Changer’ for Pulmonary Arterial HypertensionBioSpace Merck’s (MRK) Winrevair for Rare High Blood Pressure Disorder Approved by FDABloomberg Merck’s $11.5 Billion […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","footnotes":""},"categories":[6],"tags":[],"class_list":{"0":"post-105612","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-business","7":"entry"},"_links":{"self":[{"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/posts\/105612","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/comments?post=105612"}],"version-history":[{"count":0,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/posts\/105612\/revisions"}],"wp:attachment":[{"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/media?parent=105612"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/categories?post=105612"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/tags?post=105612"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}